NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders.
作者信息
Ma Zonghui, Zhou Jia
机构信息
Chemical Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch (UTMB), Galveston, Texas 77555, United States.
出版信息
J Med Chem. 2025 Jul 24;68(14):14129-14136. doi: 10.1021/acs.jmedchem.5c01818.
PMID:40702893
Abstract
摘要
Zotero 插件